2912
S. Stute et al. / Tetrahedron 61 (2005) 2907–2912
OMe); 7.4 (m, 2H, ortho-H); 7.8–8.1 (m, 14H, H-Ar); 8.6 (2d,
4H, b-pyrrole); 8.9 (s, 2H, b-pyrrole); 9.5 (dd, 2H, b-thiophene).
ESI-MS (C75 V) obsd mass 898, calcd mass 898.52.
(0.13 mmol, 16 ml) and DDQ (2.6 mmol, 0.59 g). The
crude product was purified by two silica gel column
chromatographies (chloroform) and the product afforded
as a orange-purple, crystalline solid (82 mg, 7%).
4.2.15. 5-(2-Allyloxy-5-bromo)phenyl-10,15,20-(4-bro-
mo)phenyl-21-thiaporphyrin 15. Preparation of 15 fol-
lowed the same steps like the preparation of 8, using dry
CH2Cl2 (250 ml), 4 (1.96 mmol, 1 g), 4-bromobenzalde-
hyde (3.92 mmol, 0.72 g) and pyrrole (5.88 mmol, 410 ml).
After BF3$OEt2 (0.2 mmol, 25 ml) was added, the mixture
was stirred for 3 h before DDQ (3.92 mmol, 0.89 g) was
added. The crude product was purified by silica gel column
chromatography (chloroform). After another silica gel
column chromatography (n-heptane/chloroform 1:2) 15
was isolated as a purple, crystalline solid (300 mg, 15%).
1H NMR (CDCl3, d in ppm) K2.75 (bs, 1H, NH); 4.0 (s, 9H,
OMe); 4.4 (s, 2H, OCH2); 4.6 (dd, 2H, CH2); 5.45 (dq, 1H,
CH);7.35(d, 1H, H-Ar);7.4(t, 1H, H-Ar);7.75(dt,1H, H-Ar);
8.0 (d, 1H, H-Ar); 8.3–8.7 (m, 16H, H-Ar, b-pyrrole); 8.9 (s,
2H, b-pyrrole); 9.5 (s, 2H, b-thiophene). ESI-MS (C75 V)
obsd mass 862, 841 [MKallyl], calcd mass 861.98.
References and notes
1H NMR (CDCl3, d in ppm) K2.75 (bs, 1H, NH); 4.4
(m, 2H, OCH2); 4.6 (dd, 2H, CH2); 5.4 (dq, 1H, CH); 7.2
(dd, 1H, H-Ar); 7.8 (dd, 1H, H-Ar); 7.85–8.1 (12H, H-Ar);
8.15 (d, 1H, H-Ar); 8.6 (2 d, 4H, b-pyrrole); 8.9 (s, 2H,
b-pyrrole); 9.65 (dd, 2H, b-thiophene). ESI-MS (C75 V)
obsd mass 1003, 962 [MKallyl], calcd mass 1003.45.
1. Ulman, A.; Manassen, J. J. Am. Chem. Soc. 1975, 97,
6540–6544.
2. Latos-Grazynski, L. In Kadish, K. M., Smith, K. M., Guilard,
R., Eds.; The Porphyrin Handbook; Academic Press: New
York, 2000; Vol. 2, pp 361–416.
3. Broadhurst, M. J.; Grigg, R.; Johnson, A. W. J. Chem. Soc. C
1971, 3681–3690.
4.2.16. 5-(2-Methoxy-5-bromo)phenyl-10,15,20-(4-bro-
mo)phenyl-21-thiaporphyrin 16. Compound 16 was
synthesized using the general procedure (s. 8), with dry
CH2Cl2 (450 ml), diol 5 (3.1 mmol, 1.49 g), 4-bromobenz-
aldehyde (6.2 mmol, 1.14 g), pyrrole (9.2 mmol, 640 ml),
BF3$OEt2 (0.3 mmol, 37 ml) and DDQ (6.2 mmol, 1.396 g).
The purification of the product was done by silica gel
column chromatography (chloroform). After another silica
gel column chromatography (n-heptane/chloroform 1:2) 16
was obtained as a purple, crystalline solid (270 mg, 9%).
4. (a) Ulman, A.; Manassen, J.; Frolow, F.; Rabinovich, D. Inorg.
Chem. 1981, 20, 1987–1990. (b) Pandian, R. P.;
Chandrashekar, T. K. Inorg. Chem. 1994, 33, 3317–3324.
5. (a) Gopinath, C. S.; Pandian, R. P.; Manoharan, P. T. J. Chem.
Soc., Dalton Trans. 1996, 1255–1259. (b) Ulman, A.;
Manassen, J.; Frolow, F.; Rabinovich, D. Tetrahedron Lett.
1978, 167–170. (c) Ulman, A.; Manassen, J.; Frolow, F.;
Rabinovich, D. Tetrahedron Lett. 1978, 1885–1886.
6. Hilmey, D. G.; Abe, M.; Nelen, M. I.; Stilts, C. E.; Baker,
G. A.; Baker, S. N.; Bright, F. V.; Davies, S. R.; Gollnick,
S. O.; Oseroff, A. R.; Gibson, S. L.; Hilf, R.; Detty, M. R.
J. Med. Chem. 2002, 45, 449–461.
1H NMR (CDCl3, d in ppm) K2.75 (bs, 1H, NH); 3.55 (s,
3H, OMe); 7.2 (d, 1H, H-Ar); 7.8–8.1 (m, 14H, H-Ar); 8.55
(dd, 2H, b-pyrrole); 8,6 (dd, 2H, b-pyrrole); 8,9 (d, 2H,
b-pyrrole); 9,6 (dd, 2H, b-thiophene). ESI-MS (C75 V)
obsd mass 977, calcd mass 977.42.
7. Cho, W.-S.; Kim;, H.-J.; Littler, B. J.; Miller, M. A.; Lee,
C.-H.; Lindsey, J. S. J. Org. Chem. 1999, 64, 7890–7901.
8. (a) Agarwal, N.; Hung, C.-H.; Ravikanth, M. Eur. J. Org.
Chem. 2003, 19, 3730–3734. (b) Gupta, I.; Agarwal, N.;
Ravikanth, M. Eur. J. Org. Chem. 2004, 1693–1697.
9. Felber, B.; Calle, C.; Schweiger, A.; Diederich, F. Org.
Biomol. Chem. 2003, 1, 1090–1093.
4.2.17. 5-(2-Allyloxy-3-methoxy)phenyl-10,15,20-(3,5-
methoxy)phenyl-21-thiaporphyrin 17. Compound 17
was prepared in the general procedure (s. 8), with dry
CH2Cl2 (100 ml), 6 (1.4 mmol, 0.61 g), 4-bromobenzalde-
hyde (2.8 mmol, 0.456 g) and pyrrole (4.1 mmol, 290 ml),
BF3$OEt2 (0.14 mmol, 17 ml) and DDQ (2.8 mmol,
0.635 g). After two silica gel column chromatographies
(chloroform) the product was isolated as a orange-purple,
crystalline solid (50 mg, 4%).
10. Finikova, O.; Galkin, A.; Rozhkov, V.; Cordero, M.;
¨ ¨
Hagerhall, C.; Vinogradov, S. J. Am. Chem. Soc. 2003, 125,
4882–4893.
11. Matos, M. S.; Hofkens, J.; Verheijen, W.; De Schryver, F. C.;
Hecht, S.; Pollak, K. W.; Frechet, J. M. J.; Forier, B.; Dehaen,
W. Macromolecules 2000, 33, 2967–2973.
1H NMR (CDCl3, d in ppm) K2.75 (bs, 1H, NH); 4.0 (s,
18H, OMe); 4.1 (s, 3H, OMe); 4.1 (s, 2H, OCH2); 4.3 (dd,
2H, CH2); 4.9 (dq, 1H, CH); 6.9 (d, 6H, ortho-H); 7.4 (m,
8H, H-Ar); 7.65 (dd, 1H, H-Ar); 8.65 (s, 2H, b-pyrrole);
8.7 (d, 1H, b-pyrrole); 8.75 (d, 1H, b-pyrrole); 9.02 (s, 2H,
b-pyrrole); 9.7 (d, 2H, b-thiophene). ESI-MS (C75 V) obsd
mass 898, 857 [MKallyl], calcd mass 898.06.
12. Osuka, A.; Kim, D. Acc. Chem. Res. 2004, 37, 735–745.
13. Ulman, A.; Manassen, J. J. Chem. Soc., Perkin Trans. 1 1979,
4, 1066–1069.
14. Lindsey, J. S.; Schreimann, I. C.; Hsu, H. C.; Kearney, P. C.;
Marguerettaz, A. M. J. Org. Chem. 1987, 52, 827–836.
15. Chmielewski, P.; Grzeszczcuk, M.; Latos-Grazynski, L.;
Lisowski, J. Inorg. Chem. 1989, 28, 3546–3552.
16. Adler, A. D.; Longo, F. R.; Finarelli, J. D.; Goldmacher, J.;
Assour, J.; Korsakoff, L. J. Org. Chem. 1967, 32, 476.
17. Latos-Grazynski, L.; Lisowski, J. J. Am. Chem. Soc. 1987,
109, 4428–4429.
4.2.18.
5-(2-Allyloxy)phenyl-10,15,20-(4-carboxy-
methyl)phenyl-21-thiaporphyrin 18. Preparation of 18
was prepared in analogue to 8, using dry CH2Cl2 (100 ml), 7
(1.3 mmol, 0.534 g), methyl 4-formylbenzoate (2.6 mmol,
0.426 g) and pyrrole (3.9 mmol, 270 ml), BF3$OEt2
18. Srinivasan, A.; Srivedi, B.; Reddy, M. V. R.; Narayanan, S. J.;
Chandrashekar, T. K. Tetrahedron Lett. 1997, 38, 4149–4152.